Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence And Serotypes Of Invasive Pneumococcal Disease, After The Introduction Of The Heptavalent Conjugated Vaccine In Greece

NCT01111214 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01111214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01111214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence And Serotypes Of Invasive Pneumococcal Disease, After The Introduction Of The Heptavalent Conjugated Vaccine In Greece
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
November 30, 2011
Completion date
November 30, 2012
Enrollment
457 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal disease